Asoprisnil Ecamate

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameAsoprisnil Ecamate
Drug Alias Name阿索立尼酯ecamato de asoprisniloasoprisnili ecamasasoprisnilJ-956 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgesterone receptor modulators
TargetsProgesterone receptor
Therapy Area/IndicationsMetrorrhagiaMenorrhagiaLeiomyoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJenapharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsMetrorrhagiaMenorrhagiaLeiomyoma

Other Information

ATC CodeN/A
Related LinksWikipedia